Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2012
03/29/2012WO2012037878A1 Nucleic acid index and application thereof
03/29/2012WO2012037875A1 Dna tags and use thereof
03/29/2012WO2012006732A8 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction
03/29/2012WO2011139974A3 Anti-pai-1 antibodies and methods of use thereof
03/29/2012WO2011116107A3 Cleavable modifications to reducible poly (amido ethylenimines)s to enhance nucleotide delivery
03/29/2012WO2011022387A8 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility
03/29/2012US20120077969 Nucleic acid purification method
03/29/2012US20120077968 Nucleic acid sequences encoding an1-like zinc finger proteins
03/29/2012US20120077960 Fluorobodies: intrinsically fluorescent binding ligands
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077865 Methods for treating hypercholesterolemia
03/29/2012US20120077863 Guanidino-substituted bi-and polyphenyls as small molecule carriers
03/29/2012US20120077862 Antisense modulation of ptp1b expression
03/29/2012US20120077757 Methods for Affecting Homology-Directed DNA Double Stranded Break Repair
03/29/2012US20120077738 Compositions and methods for predicting hcv susceptibility to antiviral agents
03/29/2012US20120077716 System and method for producing functionally distinct nucleic acid library ends through use of deoxyinosine
03/29/2012US20120077285 Layering for separating particles
03/29/2012US20120077270 Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide
03/29/2012US20120077265 MicroRNA and Methods for Inhibiting Same
03/29/2012US20120077200 Primers for diagnosing avellino corneal dystrophy
03/29/2012US20120077195 Method for Detecting Variations in Nucleic Acid Sequences
03/29/2012US20120077191 Genotyping dna
03/29/2012US20120077186 Use of cysteine-derived suppressor trnas for non-native amino acid incorporation
03/29/2012US20120076836 Polyion complex of double-stranded ribonucleic acid
03/29/2012US20120076794 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120074925 Assay Methods Using Nicking Endonucleases
03/28/2012EP2434022A2 Use of A33 antigens and JAM-IT
03/28/2012EP2434016A2 Expression of mammalian proteins in Pseudomonas fluorescens
03/28/2012EP2434008A1 Laccases for pulp bio-bleaching
03/28/2012EP2433950A1 DNA sequencing by parallel oligonucleotide extensions
03/28/2012EP2433949A1 DNA sequencing by parallel oligonucleotide extensions
03/28/2012EP2432880A1 Targeting micrornas for metabolic disorders
03/28/2012EP2432797A2 Phytases, nucleic acids encoding them and methods for making and using them
03/28/2012EP2432796A2 Universal tags with non-natural nucleobases
03/28/2012EP2432795A1 Dna glycosylase/lyase and ap endonuclease substrates
03/28/2012EP2432794A1 Trans-acting rna switches
03/28/2012EP2432793A2 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus
03/28/2012EP2432477A1 Methods and devices for improved efficiency of rna delivery to cells
03/28/2012EP2046807B1 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
03/28/2012EP1954706B1 Method using reversibly blocked tagging oligonucleotides
03/28/2012EP1392866B1 Novel method for cloning variable domain sequences of immunological gene repertoire
03/28/2012CN1780920B Gene expression suppression agents
03/28/2012CN102395595A Treatment of restless leg syndrome and sleep disorders
03/28/2012CN102395374A Methods of treating cancers with her3 antisense oligonucleotides
03/28/2012CN101619347B Application of oligonucleotide genin BC15 in specially recognizing tumor cells
03/27/2012US8145436 Method and systems for identifying micro-RNA targets and synthesizing novel micro-RNAs and uses of the same
03/27/2012US8143486 Delta-5 desaturase and uses thereof
03/27/2012US8143485 FAD-2 mutants and high oleic plants
03/27/2012US8143480 Compositions and methods for efficient gene silencing in plants
03/27/2012US8143479 Plastidic phosphoglucomutase genes
03/27/2012US8143477 All-native recombinant plant
03/27/2012US8143475 Soybean promoter LTP4 and flower-preferred expression thereof in transgenic plants
03/27/2012US8143473 DGAT genes from Yarrowia lipolytica for increased seed storage lipid production and altered fatty acid profiles in soybean
03/27/2012US8143390 Compositions and methods for inhibiting expression of anti-apoptotic genes
03/27/2012US8143389 Inhibiton of metallo-β-lactamase by double-stranded DNA
03/27/2012US8143388 enables assessment of dynamic variations in a mixed population of organisms using affinity aided solution hybridization combined with resolution providing fractionation; very sensitive; allow quantitative detection of polynucleotide sequences present in diminutive amounts
03/27/2012US8143387 Engineered antibody-stress protein fusions
03/27/2012US8143386 Fusion proteins of mycobacterium tuberculosis antigens and their uses
03/27/2012US8143385 Nucleic acids coding for antibodies against human IL-21 receptor and uses therefor
03/27/2012US8143384 Mutation of PRPS1 gene causing CMTX5 disease and the use thereof
03/27/2012US8143383 Δ-6 desaturase and uses thereof
03/27/2012US8143233 RNA aptamers and methods for identifying the same
03/27/2012US8143232 Gene fusion targeted therapy
03/27/2012US8143231 Method of reducing HIV-replication in human body tissue
03/27/2012US8143230 Compounds and methods for modulating expression of PCSK9
03/27/2012US8143060 Method of assessing the viability of thawed developmentally competent embryos
03/27/2012US8143056 Vascular adhesion molecules and modulation of their function
03/27/2012US8143050 Recombinant β-glucosidase variants for production of soluble sugars from cellulosic biomass
03/27/2012US8143049 Modified beta-glucosidases with improved stability
03/27/2012US8143048 Non-maltogenic exoamylase for use in improving quality of dough and baked goods
03/27/2012US8143047 Polypeptides of botryosphaeria rhodina
03/27/2012US8143036 Genetically modified microorganisms for producing itaconic acid with high yields
03/27/2012US8143032 Alleles of the thrA gene of Enterobacteriaceae
03/27/2012US8143027 Method of making a plasminogen activator polypeptide with clot-specific streptokinase activity
03/27/2012US8143025 Antibodies against vascular endothelial growth factor receptor-1
03/27/2012US8143024 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
03/27/2012US8143008 Method of nucleic acid amplification
03/27/2012US8143007 Nested primer sets for amplifying mouse immunoglobulin variable gene segments
03/27/2012US8143005 Nucleic acids encoding sodium channel SCN1A alpha subunit proteins and mutations associated with epilepsy
03/27/2012US8143002 Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes
03/27/2012US8143001 Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
03/27/2012US8143000 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
03/27/2012US8142794 Hepatitis C virus vaccine
03/27/2012CA2421087C Antisense insulin-like growth factor binding protein (igfbp)-2 oligodeoxynucleotides for prostate and other endocrine tumor therapy
03/22/2012WO2012037254A1 MODIFIED iRNA AGENTS
03/22/2012WO2012037107A1 Compositions and methods for xylem-specific expression in plant cells
03/22/2012WO2012037038A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
03/22/2012WO2012036972A1 Chemical modification of rna at the 2'-position of the ribose ring via aaa coupling
03/22/2012WO2012036706A1 Bacterial cells, optimized nucleotide sequences and methods for improved expression of recombinant clostridium difficle toxin b
03/22/2012WO2012034194A1 Method for mobilizing stem and/or progenitor cells
03/22/2012WO2012034177A1 Capture based nucleic acid detection
03/22/2012WO2011153323A3 Compositions and methods directed to treating liver fibrosis
03/22/2012WO2011130557A3 Phosphonates with reduced toxicity for treatment of viral infections
03/22/2012WO2006046250A3 Compositions and methods for diagnosing and treating insulin resistance
03/22/2012US20120073023 Novel gene regulating tillering and leaf morphology in plant and utilization of the same
03/22/2012US20120073004 Hybrid Light Chain Mice
03/22/2012US20120073003 Apobec3 mediated dna editing
03/22/2012US20120073001 Methods and compositions for treating or preventing pruritis
03/22/2012US20120071644 Compounds for fluorescent labeling
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 899